Lipopolysaccharide attenuates thrombolysis in batroxobin-induced lung vasculature fibrin deposition but not in ferrous chloride-induced carotid artery thrombus in rats: Role of endogenous PAI-1

Thrombosis Research

Volumn 111, Issue 6, 2003, Pages 381-387

  Wang, Yi Xin ^a   Dong, Ningzheng ^a,b   Wu, Chengliang ^a,b   Martin McNulty, Baby ^a   Fitch, Richard M ^a   Da Cunha, Valdeci ^a   Vicelette, Jon ^a   Tran, Katherine ^a   Vergona, Ronald ^a   Sullivan, Mark E ^a   Morser, John ^a   Wu, Qingyu ^a  

^a BAYER AG   (Germany)

^b SUZHOU UNIVERSITY   (China)

Author keywords

125I labeled fibrinogen; Batroxobin; FeCl2; Fibrinolysis; PAI 1; TPA

Indexed keywords

BATROXOBIN; FERROUS CHLORIDE; IODINE 125; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BLOOD LEVEL; CAROTID ARTERY THROMBOSIS; DOSE RESPONSE; ENDOTHELIUM INJURY; FIBRIN DEPOSITION; FIBRINOLYSIS; ISOTOPE LABELING; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOGENESIS; THROMBUS;

EID: 0346787801     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.026     Document Type: Article

References (31)

1. Haskel E.J., Adams S.P., Feigen L.P., Saffitz J.E., Gorczynski R.J., Sobel B.E.et al. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors. Circulation. 80:1989;1775-1782.
2. Collen D., Lijnen H.R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:1991;3114-3124.
3. Vassalli J.D., Sappino A.P., Belin D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1991;1067-1072.
4. Loskutoff D.J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog. Hemostasis Thromb. 9:1989;87-115.
5. Sprengers E.D., Kluft C. Plasminogen activator inhibitors. Blood. 69:1987;381-387.
6. Emeis J.J., Kooistra T. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J. Exp. Med. 163:1986;1260-1266.
7. Suffredini A.F., Harpel P.C., Parrillo J.E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med. 320:1989;1165-1172.
8. Levi M., ten Cate H., Bauer K.A., van der Poll T., Edgington T.S., Buller H.R.et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:1994;114-120.
9. Padro T., Quax P.H., van den Hoogen C.M., Roholl P., Verheijen J.H., Emeis J.J. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Arterioscler. Thromb. 14:1994;1459-1465.
10. Krishnamurti C., Barr C.F., Hassett M.A., Young G.D., Alving B.M. Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits. Blood. 69:1987;798-803.
11. Carmeliet P., Stassen J.M., Schoonjans L., Ream B., van den Oord J.J., De Mol M.et al. Plasminogen activator inhibitor-1 gene-deficient mice: II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:1993;2756-2760.
12. Wu C., Dong N., da Cunha V., Martin-McNulty B., Tran K., Nagashima M.et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs. Thromb. Haemost. 94:2003;414-421.
13. Abrahamsson T., Nerme V., Stromqvist M., Akerblom B., Legnehed A., Pettersson K.et al. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin. Thromb. Haemost. 75:1996;118-126.
14. Lee M.H., Vosburgh E., Anderson K., McDonagh J. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood. 81:1993;2357-2362.
15. Schleef R.R., Higgins D.L., Pillemer E., Levitt L.J. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J. Clin. Invest. 83:1989;1747-1752.
16. Nilsson I.M., Ljungner H., Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. BMJ (Clinical Research Ed.). 290:1985;1453-1456.
17. Aillaud M.F., Juhan-Vague I., Alessi M.C., Marecal M., Vinson M.F., Arnaud C.et al. Increased PA-inhibitor levels in the postoperative period - no cause-effect relation with increased cortisol. Thromb. Haemost. 54:1985;466-468.
18. Paramo J.A., Colucci M., Collen D., van de Werf F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. BMJ (Clinical Research Ed.). 291:1985;573-574.
19. Colucci M., Paramo J.A., Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J. Clin. Invest. 75:1985;818-824.
20. Chetaille P., Alessi M.C., Kouassi D., Morange P.E., Juhan-Vague I. Plasma TAFI antigen variations in healthy subjects. Thromb. Haemost. 83:2000;902-905.
21. Folsom A.R., Aleksic N., Park E., Salomaa V., Juneja H., Wu K.K. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 21:2001;611-617.
22. Pizzo S.V., Schwartz M.L., Hill R.L., McKee P.A. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin. J. Clin. Invest. 51:1972;2841-2850.
23. Regoeczi E., Gergely J., McFarlane A.S. In vivo effects of Agkistrodon rhodostoma venom: studies with fibrinogen-131I. J. Clin. Invest. 45:1966;1202-1212.
24. Klocking H.P., Markwardt F., Guttner J. On the mechanism of batroxobin-induced fibrinolysis. Pharmazie. 44:1989;504-505.
25. Roux S., Carteaux J.P., Hess P., Falivene L., Clozel J.P. Experimental carotid thrombosis in the guinea pig. Thromb. Haemost. 71:1994;252-256.
26. Lockyer S., Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J. Cardiovasc. Pharmacol. 33:1999;718-725.
27. Kurz K.D., Main B.W., Sandusky G.E. Rat model of arterial thrombosis induced by ferric chloride. Thromb. Res. 60:1990;269-280.
28. Falati S., Gross P., Merrill-Skoloff G., Furie B.C., Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8:2002;1175-1181.
29. Fay W., Eitzman D., Shapiro A., Madison E., Ginsburg D. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1- dependent and -independent mechanisms. Blood. 83:1994;351-356.
30. Torr-Brown S., Sobel B. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb. Res. 72:1993;413-421.
31. Erickson L., Fici G., Lund J., Boyle T., Polites H., Marotti K. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature. 346:1990;74-76.